PillLabeler · US market
Horizon Therapeutics USA, Inc.
Horizon Therapeutics USA, Inc. is a US drug labeler with US FDA registrations covering 9 drug concepts (9 currently active) across 15 packages. It is currently the only active US supplier of 6 drugs.
ACTIVE — US
openFDA · updated weekly
Labeler codes75987
Active drugs9
Registrations12 active / 12
Packages15
Sole supplier of6 drugs
Portfolio9 drugs · US
Every drug concept this labeler has US registrations for, by package count.
| Drug | Type | NDCs | Packages | Status |
|---|---|---|---|---|
| Cysteamine Bitartrate granule, delayed release | rx | 2 | 4 | SUPPLYING |
| Pegloticase injection, solution | rx | 2 | 2 | SUPPLYING |
| Cysteamine Bitartrate capsule, delayed release pellets | rx | 2 | 2 | SUPPLYING |
| Glycerol Phenylbutyrate liquid | rx | 1 | 2 | SUPPLYING |
| Inebilizumab injection | rx | 1 | 1 | SUPPLYING |
| Teprotumumab injection, powder, lyophilized, for solution | rx | 1 | 1 | SUPPLYING |
| Sodium Phenylbutyrate tablet | rx | 1 | 1 | SUPPLYING |
| Interferon Gamma-1b injection, solution | rx | 1 | 1 | SUPPLYING |
| Sodium Phenylbutyrate powder | rx | 1 | 1 | SUPPLYING |